quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:02:10·28d
SECFiling
Autolus Therapeutics plc logo

Autolus Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

AUTL· Autolus Therapeutics plc
Health Care
Original source

Companies

  • AUTL
    Autolus Therapeutics plc
    Health Care

Recent analyst ratings

  • Feb 17UpdateH.C. Wainwright$9.00
  • Nov 18UpdateGoldman$7.60
  • Nov 15UpdateRedburn Atlantic$13.00
  • Nov 9UpdateDeutsche Bank$10.00
  • Mar 27UpdateWells Fargo$8.00
  • Mar 17UpdateBryan Garnier$5.00

Related

  • PR2d
    Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
  • PR2d
    Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • SEC7d
    Autolus Therapeutics plc filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
  • SEC8d
    SEC Form DEL AM filed by Autolus Therapeutics plc
  • SEC9d
    SEC Form DEL AM filed by Autolus Therapeutics plc
  • SEC13d
    SEC Form S-3 filed by Autolus Therapeutics plc
  • SEC15d
    Autolus Therapeutics plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR17d
    Autolus Therapeutics to Participate in Upcoming Investor Conferences
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022